Woo, Vincent

Management of type 2 diabetes, obesity, or nonalcoholic steatohepatitis with high‐dose GLP‐1 receptor agonists and GLP‐1 receptor‐based co‐agonists

Goldenberg, R. M., Gilbert, J. D., Manjoo, P., Pedersen, S. D., Woo, V. C., & Lovshin, J. A. (2024) · Obesity Reviews

Diabetes Treatment and ManagementPharmacology and Obesity Treatment

Cited by 27

Flexibly timed once‐daily dosing with degludec: a new ultra‐long‐acting basal insulin

Josse, R. G., & Woo, V. (2013) · Diabetes, Obesity and Metabolism

Diabetes Management and ResearchDiabetes Treatment and Management

Cited by 24